SPRR2A and Granuloma: High levels of MCP-1 will limit monocyte responses and induce transforming growth factor-βexpression, selectively inhibiting Th1 immune responses bydecreasinginterleukin-12 (IL-12) and interferon-γ expression, and also influencing the formation of granuloma[17].